Smartphone App for Adolescents With Idiopathic Scoliosis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-24
SponsorOslo Metropolitan University
About this trial
This study aims to evaluate a smartphone application (DinSkoliose) designed to support adolescents with idiopathic scoliosis (AIS) in managing their condition and following their treatment.
Adolescents with AIS often find it challenging to adhere to conservative treatment, such as wearing a brace or performing physiotherapy exercises. The app was developed specifically for this study as a theory-informed digital health intervention to support self-management and treatment adherence. It includes features such as symptom tracking, educational content, reminders, and social support.
Participants will use the app for 12 weeks in their everyday environment alongside their usual care. They will complete questionnaires before and after the intervention and participate in an interview to share their experiences.
The study will examine whether the app can improve health-related behaviors, including treatment adherence and self-management, and whether it is feasible and acceptable for adolescents with scoliosis.The app is meant to complemen the current AIS treatment, doesn't substitute it.
Eligibility criteria
Qualifiers
who are diagnosed with AIS;
who give written informed consent,
who are at the age between 10 - 24 years old;
under 16 years old for whom parental consent has been provided (as required by the National Research Ethics Committee);
Disqualifiers
have a history of other type of scoliosis (such as congenital, neuromuscular, degenerative);
are younger than 10 years old and older than 24 years old;
have any additional diagnosis that could affect the intervention outcome (severe mental health disorders or diagnosis of a developmental disorder that prevents understanding and compliance with intervention, leg length discrepancy).
Trial design
Treatments tested in this trial
- DinSkoliose smartphone application
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Oslo Metropolitan University
Lead sponsor
Oslo University Hospital
Collaborator
Ryggforeningen i Norge, Norway
Collaborator
Source ClinicalTrials.gov